Clinical trial
Single Cell Molecular Analysis of Influenza Vaccine Induced T Cell Responses in Adults 65 Years of Age or Older
NCT04077424 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Cell Molecular Analysis of Influenza Vaccine Induced T Cell Responses in Adults 65 Years of Age or Older
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 21, 2019
- Completion date
- February 1, 2020
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
flu vaccine